Phenotypic alterations in myoepithelial cells associated with benign sclerosing lesions of the breast

American Journal of Surgical Pathology

Volumn 34, Issue 6, 2010, Pages 896-900

  Hilson, Justin B ^a   Schnitt, Stuart J ^a   Collins, Laura C ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Benign sclerosing lesions; Ductal carcinoma in situ; Myoepithelial cells

Indexed keywords

BIOLOGICAL MARKER;

ARTICLE; BREAST DISEASE; EPITHELIUM CELL; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; METABOLISM; PATHOLOGY; SMOOTH MUSCLE FIBER;

BIOLOGICAL MARKERS; BREAST DISEASES; EPITHELIAL CELLS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; MYOCYTES, SMOOTH MUSCLE;

EID: 77953072767     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e3181dd60d3     Document Type: Article

References (23)

1. Adriance MC, Inman JL, Petersen OW, et al. Myoepithelial cells: good fences make good neighbors. Breast Cancer Res. 2005;7:190-197.
2. Allinen M, Beroukhim R, Cai L, et al. Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell. 2004;6:17-32. (Pubitemid 38903159)
3. Azoulay S, Lae M, Freneaux P, et al. KIT is highly expressed in adenoid cystic carcinoma of the breast, a basal-like carcinoma associated with a favorable outcome. Mod Pathol. 2005;18:1623-1631.
4. Barsky SH, Karlin NJ. Mechanisms of disease: breast tumor pathogenesis and the role of the myoepithelial cell. Nat Clin Pract Oncol. 2006;3:138-151.
5. Bhargava R, Dabbs DJ. Use of immunohistochemistry in diagnosis of breast epithelial lesions. Adv Anat Pathol. 2007;14:93-107.
6. Chivukula M, Domfeh A, Carter G, et al. Characterization of highgrade ductal carcinoma in situ with and without regressive changes: diagnostic and biologic implications. Appl Immunohistochem Mol Morphol. 2009;17:495-499.
7. Corben A, Lerwill M. Use of myoepithelial cell markers in the differential diagnosis of benign, in situ and invasive lesions of the breast. Current concepts in breast pathology. Surg Path Clinics. 2009;2:351-373.
8. Cserni G. Lack of myoepithelium in apocrine glands of the breast does not necessarily imply malignancy. Histopathology. 2008;52:253-255.
9. Deugnier MA, Teuliere J, Faraldo MM, et al. The importance of being a myoepithelial cell. Breast Cancer Res. 2002;4:224-230.
10. Hilson JB, Schnitt SJ, Collins LC. Phenotypic alterations in ductal carcinoma in situ-associated myoepithelial cells: biologic and diagnostic implications. Am J Surg Pathol. 2009;33:227-232.
11. Hu M, Yao J, Cai L, et al. Distinct epigenetic changes in the stromal cells of breast cancers. Nat Genet. 2005;37:899-905.
12. Lakhani SR, O'Hare MJ. The mammary myoepithelial cell-Cinderella or ugly sister? Breast Cancer Res. 2001;3:1-4.
13. Lamovec J, Us-Krasovec M, Zidar A, et al. Adenoid cystic carcinoma of the breast: a histologic, cytologic, and immunohistochemical study. Semin Diagn Pathol. 1989;6:153-164.
14. Lerwill MF. Current practical applications of diagnostic immunohistochemistry in breast pathology. Am J Surg Pathol. 2004;28:1076-1091.
15. Moriya T, Kanomata N, Kozuka Y, et al. Usefulness of immunohistochemistry for differential diagnosis between benign and malignant breast lesions. Breast Cancer. 2009;16:173-178.
16. Polyak K, Hu M. Do myoepithelial cells hold the key for breast tumor progression? J Mammary Gland Biol Neoplasia. 2005;10:231-247.
17. Rosen PP. Breast Pathology. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2009.
18. Seal M, Wilson C, Naus GJ, et al. Encapsulated apocrine papillary carcinoma of the breast-a tumour of uncertain malignant potential: report of five cases. Virchows Arch. 2009;455:477-483.
19. Schnitt SJ. The transition from ductal carcinoma in situ to invasive breast cancer: the other side of the coin. Breast Cancer Res. 2009;11:101.
20. Sternlicht MD, Barsky SH. The myoepithelial defense: a host defense against cancer. Med Hypotheses. 1997;48:37-46.
21. Sternlicht MD, Kedeshian P, Shao ZM, et al. The human myoepithelial cell is a natural tumor suppressor. Clin Cancer Res. 1997;3:1949-1958.
22. Wang NP, Bing BC, Skelly M, et al. Antibodies to novel myoepithelium-associated proteins distinguish benign lesions and carcinoma in situ from invasive carcinoma of the breast. Appl Immunohistochem. 1997;5:141-151.
23. Yeh IT, Mies C. Application of immunohistochemistry to breast lesions. Arch Pathol Lab Med. 2008;132:349-358.